摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-amino-benzyl)-(7(9)H-purin-6-yl)-amine | 73214-94-5

中文名称
——
中文别名
——
英文名称
(2-amino-benzyl)-(7(9)H-purin-6-yl)-amine
英文别名
N-[(2-aminophenyl)methyl]-7H-purin-6-amine
(2-amino-benzyl)-(7(9)<i>H</i>-purin-6-yl)-amine化学式
CAS
73214-94-5
化学式
C12H12N6
mdl
MFCD15501365
分子量
240.267
InChiKey
SPRRYSQZCZWSEW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.083
  • 拓扑面积:
    92.5
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS
    申请人:Havlicek Libor
    公开号:US20110287111A1
    公开(公告)日:2011-11-24
    The invention relates to new substituted 6-(2-aminobenzylamino)purines, represented by the general formula I, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical preparations containing substituted 6-(2-aminobenzylamino)purines.
    本发明涉及一种新型的取代6-(2-基苯基基)嘌呤,其通式为I,可用于CDK抑制,特别是用于治疗病毒感染和涉及细胞增殖的疾病。本发明还包括含有取代的6-(2-基苯基基)嘌呤的药物制剂。
  • Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
    申请人:Dolezal Karel
    公开号:US20050043328A1
    公开(公告)日:2005-02-24
    New heterocyclic derivatives based on N 6 -substituted adenine, having anticancer, mitotic, imunosuppressive and antisenescent propoerties for plant, animal and human cells and methods of their preparation. Included are also pharmaceutical compositions, cosmetic preparations and growth regulators, which contain these derivatives as active compound and the use of these derivatives for the preparation of drugs, cosmetic preparations, in biotechnological processes, in cosmetics and in agriculture.
    基于N6-取代腺嘌呤的新杂环衍生物具有抗癌、有丝分裂、免疫抑制和抗衰老的性质,适用于植物、动物和人类细胞,并提供其制备方法。还包括含有这些衍生物作为活性化合物的药物组合物、化妆品制剂和生长调节剂,以及这些衍生物用于制备药物、化妆品制剂、生物技术过程、化妆品和农业的用途。
  • HETEROCYCLIC COMPOUNDS BASED ON N6-SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS
    申请人:Popa Igor
    公开号:US20080014227A1
    公开(公告)日:2008-01-17
    Novel heterocyclic derivatives based on N 6 -substituted adenine, having anticancer, mitotic, immunosuppressive and antisenescent properties for plant, animal and human cells and methods of their preparation. Included are also pharmaceutical compositions, cosmetic preparations and growth regulators, which contain these derivatives as active compound and the use of these derivatives for the preparation of drugs, cosmetic preparations, in biotechnological processes, in cosmetics and in agriculture.
    基于N6-取代腺嘌呤的新型杂环衍生物,具有抗癌、有丝分裂、免疫抑制和抗衰老的性质,适用于植物、动物和人类细胞,以及它们的制备方法。还包括含有这些衍生物作为活性化合物的制药组合物、化妆品制剂和生长调节剂,以及使用这些衍生物制备药物、化妆品制剂、生物技术过程、化妆品和农业的方法。
  • [EN] SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS<br/>[FR] DÉRIVÉS DE 6-(2-AMINOBENZYLAMINO)PURINE SUBSTITUÉE, UTILISATION DE CEUX-CI EN TANT QUE MÉDICAMENTS, ET PRÉPARATIONS CONTENANT CES COMPOSÉS
    申请人:UNIVERZITA PALACKEHO V OLOMOUC
    公开号:WO2010085924A3
    公开(公告)日:2010-09-30
  • HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp &minus;SUBSTITUTED ADENINE&comma; METHODS OF THEIR PREPARATION&comma; THEIR USE FOR PREPARATION OF DRUGS&comma; COSMETIC PREPARATIONS AND GROWTH REGULATORS&comma; PHARMACEUTICAL PREPARATIONS&comma; COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE
    申请人:Ustav Experimentalni Botaniky Akademie ved Ceské Republiky
    公开号:EP1419157A2
    公开(公告)日:2004-05-19
查看更多